Management
Michael Singer
Chief Executive Officer
Michael Singer brings more than 20 years of executive leadership, healthcare and financial experience to BrainScope. He most recently was President, Revolution Health Investments, Revolution LLC, where he oversaw the health-related portfolio at Revolution. In particular he managed all external activities (partnerships, M&A, and investments) and assessed all new business opportunities at Revolution Health Group. Among his key achievements, he initiated, negotiated and completed several transactions that together created the Revolution Health Network and was instrumental in the merger of Revolution Health with Waterfront Media.
Prior to Revolution, Mr. Singer was an executive at Microsoft Corporation reporting directly to the Chief Technical Officer. His responsibilities included developing small business and healthcare strategies. Prior to this he was the Chief Financial Officer, Executive Vice President of Corporate Development and a Board member for Data Critical Corporation, a Seattle-based venture-backed wireless healthcare informatics and medical device company. At Data Critical he was responsible for facilitating the company’s IPO, overseeing all financial functions, managing acquisitions and partnerships and eventually led the sale of Data Critical to GE.
Prior to his executive appointments, Mr. Singer was a healthcare investment banker and M&A generalist for New York-based Wolfensohn & Co., and San-Francisco-based Montgomery Securities and Alex Brown.
Mr. Singer holds a Ph.D. from the London School of Economics.
Leslie Prichep, Ph.D.
Prof. of Psychiatry, NYU School of Medicine
Leslie Prichep is the Associate Director of Brain Research Laboratories (BRL), a Professor of Psychiatry at NYU School of Medicine and a Research Scientist at the Nathan Kline Institute for Psychiatric Research, NY State Department of Mental Hygiene. She has extensive research experience using quantitative analysis of brain electrical activity in the study of normal subjects, patients with neuropsychiatric disorders, patients with learning and cognitive disorders, and patients with disturbances in consciousness.
Through funded studies over the years, Dr. Prichep and her colleagues at BRL have contributed significantly to a better understanding of the pathophysiology in such disorders and in building the bridges between such information and optimization of treatment outcome and evolution of disorders. Dr. John (then Director of BRL), Dr. Prichep and their team, were the first to publish normative equations demonstrating that features of the EEG were lawful as a function of age. These norms (age 6-90 years) have been replicated in over 10 countries, demonstrating the norms to be culture and ethnic free. The database of electrophysiological data constructed over the past 30 years is the largest of its kind in the world and is the foundation of both current and future research. Dr. Prichep sits on the Boards of the International Pharmaco-EEG Society (IPEG) and the EEG and Clinical Neuroscience Society (ECNS). She has nearly 100 publications and is considered one of the preeminent research scientists in the field of computerized electrophysiological in psychiatry.
Neil Rothman, Ph.D.
Executive Director, Product Development
Dr. Rothman brings over 30 years of product development and senior management experience to BrainScope. Prior to joining BrainScope, Dr. Rothman was the VP of Research and Development for Infinite Biomedical Technologies (IBT), leading the development of EEG based systems for detection of asphyxic brain injury and seizures in critical care applications, achieving two 510(k) cleared products in three years. He was also responsible for implementation of the company’s quality management system.
Before IBT, Dr. Rothman was a consultant to GE Healthcare’s Maternal and Infant Care Division, leading the implementation of a new Product Data Management system to integrate their product development operations with the GE Oracle Enterprise Resource Planning system. Dr. Rothman was also the VP of Operations for Metasensors (a startup company developing a microfluidic system for respiratory gas analysis), Director of Engineering for IGEN International (manufacturer of systems for high throughput drug screening, food testing, and clinical diagnostics), and Senior VP and Chief Technical Officer for CardioLogic Systems (a startup company developing automated systems for cardiopulmonary resuscitation and cardiac assist). He also held a variety of positions at the Johns Hopkins Applied Physics Laboratory and Black & Decker’s medical products division. He teaches in the areas of technology commercialization and engineering management and has 11 patents.
Dr. Rothman holds a BS in Biomedical Engineering and MS in Mechanical Engineering from Rensselaer Polytechnic Institute and a PhD in Mechanical Engineering from the Johns Hopkins University.
Douglas C. Oberly, MS
Executive Director, Clinical Affairs
Mr. Oberly brings over 15 years of clinical experience in the areas of Critical Care, Emergency Medicine, and Air Medical Transport. He most recently served as a Clinical Specialist with Respironics, Inc. providing education and sales support for the Critical Care Division. He was also a Clinical Manager at Hartford Hospital in Hartford, Connecticut overseeing clinical practice, research, and education,. He has provided clinical consulting in the areas of product development and clinical utility to numerous medical device and pharmaceutical companies. He has received research and presentation awards from the American College of CHEST Physicians and the Undersea Hyperbaric Medicine Society.
Mr. Oberly received his M.S. in Management from Rensselaer Polytechnic Institute Lally School of Management & Technology, and his B.S. degree in Respiratory Therapy from York College of Pennsylvania.